TRiCares

Focus: TRiCares is a German medical device company specializing in transcatheter heart valve prosthesis, particularly for tricuspid valve replacement. The company is in Series C+ funding stage, positioning it as a growth-stage innovator in the cardiovascular device market.

Cardiovascular Metabolic Diseases

Profile data last refreshed Yesterday · AI intelligence enriched 2w ago

Funding Stage

SERIES C +

Open Jobs

About TRiCares

AI assessmentNot Hiring

No open roles listed right now. Follow TRiCares to get notified when they start hiring — the background below is worth knowing for when they do.

Why Work Here

Data completeness

1/9 — Limited

Company HealthSolid

Pipeline

Early-stage

3 total

LOE Risk

Protected

No near-term cliffs

Hiring

0 open

Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.

Pipeline & Clinical Trials

Transcatheter Tricuspid Valve Replacement

Tricuspid Valve Regurgitation

N/A

Clinical Trials (1)

NCT06581471The TRICURE EU Pivotal Study

N/A

Help build intelligence for TRiCares

No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.

Share Interview Share Compensation

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.

Focused pipeline in high-unmet-need cardiovascular space (tricuspid regurgitation) with active clinical programs
Early-stage growth company (Series C+) offers equity upside potential and direct impact on product development
Balanced hiring across Clinical Operations, Commercial, Engineering, and Regulatory Affairs signals multi-functional maturation

Watch Out For

Limited public visibility: no published research output and minimal recent news make it difficult to assess clinical momentum or market traction
Small headcount and 7 active roles suggest constrained resources and limited career infrastructure compared to established medtech players
Transcatheter device market is highly competitive with well-funded rivals; regulatory path and reimbursement success remain unproven

Generated by Claude from TRiCares's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.

Transcatheter Tricuspid Valve Replacement

Tricuspid Valve Regurgitation

N/A

Clinical Trials (1)

NCT06506942The TRICURE EFS Study

N/A

Topaz TTVR System

Tricuspid Regurgitation

N/A

Clinical Trials (1)

NCT05126030The TRICURE First in Human Trial

N/A

Open Jobs (0)

No open positions listed yet. Check their careers page directly.

Interview Prep Quick Facts

Portfolio: 3 clinical trials

Pro Feature

Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.

Upgrade to Pro — $25/mo